Asthma update: Part I. Diagnosis, monitoring, and prevention of disease progression

American Family Physician

Volumn 70, Issue 5, 2004, Pages 893-898

  Mintz, Matthew ^a,b  

^a G W Univ Sch Med Hlth Sci   (United States)

^b G W Univ Sch of Med/Hlth Sci ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AIRWAY OBSTRUCTION; ANAMNESIS; ASTHMA; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CORTICOSTEROID THERAPY; COUGHING; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; FOREIGN BODY; HEART DISEASE; HUMAN; LUNG EMBOLISM; LYMPH NODE HYPERPLASIA; MORBIDITY; MORTALITY; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; REVIEW; RHINOSINUSITIS; SELF CARE; SPIROMETRY; SYMPTOMATOLOGY; TUMOR; WHEEZING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; CHILD; DIAGNOSIS, DIFFERENTIAL; FAMILY PRACTICE; HUMANS; PEAK EXPIRATORY FLOW RATE; PRACTICE GUIDELINES; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 4444380035     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma - 1980-1999. MMWR Surveill Summ 2002;51:1-13.
2. Mintz M. Asthma update: Part II. Medical management. Am Fam Physician 2004. In press.
3. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: expert panel report 2. Bethesda, Md.: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, 1997; NIH publication no. 97-4051.
4. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics - 2002. Bethesda, Md.: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, 2003; NIH publication no. 02-5074.
5. Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM. Asthma variability in patients previously treated with β-agonists alone. J Allergy Clin Immunol 2003;112: 1088-94.
6. Asthma in America. Asthma statistics. Accessed online June 3, 2004, at: http://www.asthmainamerica.com/statistics.htm.
7. Fuhlbrigge AL, Adams RJ, Guilbert TW, Grant E, Lozano P, Janson SL, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the National Asthma Education and Prevention Program guidelines. Am J Respir Crit Care Med 2002;166:1044-9.
8. Management of chronicasthma. Rockville, Md.: Agency for Healthcare Research and Quality; File inventory, Evidence report/technology assessment no. 44; AHRQ publication no. 01-E044, September 2001. Accessed online June 3, 2004, at: http://www.ahcpr.gov/clinic/astmainv.htm.
9. 1 is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001;107:61-7.
10. Abramson MJ, Bailey MJ, Couper FJ, Driver JS, Drummer OH, Forbes AB, et al. Are asthma medications and management related to deaths from asthma? Am J Respir Crit Care Med 2001;163:12-8.
11. Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2004;(1):CD001117.
12. Elias JA, Zhu Z, Chupp G, Homer RJ. Airway remodeling in asthma. J Clin Invest 1999;104:1001-6.
13. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997;111:852-7.
14. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
15. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
16. Overbeck SE, Kerstjens HA, Bogaard JM, Mulder PG, Postma DS. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch Chronic Nonspecific Lung Disease Study Group. Chest 1996;110:35-41.
17. Selroos O, Pietinalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-34.
18. Long-term effects of budesonide of nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000;343:1054-63.
19. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.
20. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-9.
21. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-200.